Hemispherx Biopharma(HEB)2019-07-23 11:45
$Hemispherx Biopharma(HEB)$ 8-K - Current report Filed: 2019-07-22 AccNo: 0001493152-19-010919 Size: 319 KBItem 1.01: Entry into a Material Definitive AgreementItem 9.01: Financial Statements and Exhibits 网页链接查看全文
Hemispherx Biopharma(HEB)2019-07-23 11:45
$Hemispherx Biopharma(HEB)$ 424B5 - Prospectus [Rule 424(b)(5)] Filed: 2019-07-22 AccNo: 0001493152-19-010927 Size: 480 KB 网页链接查看全文
Hemispherx Biopharma(HEB)2019-06-29 00:30
$Hemispherx Biopharma(HEB)$ 8-K - Current report Filed: 2019-06-28 AccNo: 0001493152-19-009853 Size: 73 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain OfficersItem 9.01: Fin...查看全文
Nicole07772016-02-18 23:51
$HEMISPHERX BIOPHARMA INC(HEB)$ slowly increseing the share price from this year! First target is between 0.15 and 0.16 price level.查看全文
Nicole07772016-02-18 04:52
$HEMISPHERX BIOPHARMA INC(HEB)$ Zika Outbreak: WHO's Global Emergency Response Plan查看全文
Nicole07772016-02-17 23:26
$HEMISPHERX BIOPHARMA INC(HEB)$ Institutional investors increased their holdings in HEB by 1.36% Q/Q, with 197,988 net purchase. 22 institutions have a holding in HEB shares. These institutional investors hold 6% of HEB's total shares and 6% of its float. Insiders and 5% ...查看全文
Nicole07772016-02-15 23:35
$HEMISPHERX BIOPHARMA INC(HEB)$ Short Interest in Hemispherx BioPharma, Inc (HEB) Increases By 77.5%查看全文
Nicole07772016-02-10 23:28
$HEMISPHERX BIOPHARMA INC(HEB)$ Zika virusZika virus effectin couple months, it can gain 100% easily查看全文
Nicole07772016-02-10 23:26
$HEMISPHERX BIOPHARMA INC(HEB)$ Hemispherx BioPharma Shares Gain; Mulls Zika Virus Research Program (NYSEMKT:HEB)
网页链接查看全文
Nicole07772016-02-10 23:24
$HEMISPHERX BIOPHARMA INC(HEB)$ Hemispherx Biopharma Incorporated (NYSEMKT:HEB) Short Interest Increased By 136.81%
网页链接查看全文
$Hemispherx Biopharma(HEB)$ 8-K - Current report Filed: 2019-08-26 AccNo: 0001493152-19-013386 Size: 83 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain OfficersItem 8.01: Oth...
$Hemispherx Biopharma(HEB)$ 8-K - Current report Filed: 2019-08-23 AccNo: 0001493152-19-013294 Size: 62 KBItem 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal YearItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接
$Hemispherx Biopharma(HEB)$ DEF 14A - Other definitive proxy statements Filed: 2019-08-20 AccNo: 0001493152-19-013142 Size: 1 MB 网页链接
$Hemispherx Biopharma(HEB)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2019-08-14 AccNo: 0001493152-19-012572 Size: 5 MB 网页链接
$Hemispherx Biopharma(HEB)$ 8-K - Current report Filed: 2019-07-22 AccNo: 0001493152-19-010919 Size: 319 KBItem 1.01: Entry into a Material Definitive AgreementItem 9.01: Financial Statements and Exhibits 网页链接
$Hemispherx Biopharma(HEB)$ 424B5 - Prospectus [Rule 424(b)(5)] Filed: 2019-07-22 AccNo: 0001493152-19-010927 Size: 480 KB 网页链接
$Hemispherx Biopharma(HEB)$ SC 13D - General statement of acquisition of beneficial ownership Filed: 2019-06-28 AccNo: 0001493152-19-009885 Size: 54 KB 网页链接
$Hemispherx Biopharma(HEB)$ 8-K - Current report Filed: 2019-06-28 AccNo: 0001493152-19-009853 Size: 73 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain OfficersItem 9.01: Fin...
$Hemispherx Biopharma(HEB)$ 内部交易: 2019-06-27,Exec. 副Chairman/CEO/Pres.,EQUELS THOMAS K. ,买入,2632普通股, $4.37
$Hemispherx Biopharma(HEB)$ 内部交易: 2019-06-21,Director,MITCHELL WILLIAM M ,买入,9677普通股, $4.03